|
Volumn 49, Issue 5, 2009, Pages 1777-1779
|
Reply
a b a b a b |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMOXICILLIN PLUS CLAVULANIC ACID;
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
ANTIINFECTIVE AGENT;
ANTILIPEMIC AGENT;
ANXIOLYTIC AGENT;
CARDIOVASCULAR AGENT;
CENTRAL NERVOUS SYSTEM AGENTS;
DICLOFENAC;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
GLUTATHIONE TRANSFERASE M1;
GLUTATHIONE TRANSFERASE T1;
IBUPROFEN;
INDOMETACIN;
MACROLIDE;
NAPROXEN;
NIMESULIDE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PIROXICAM;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
TUBERCULOSTATIC AGENT;
CASE CONTROL STUDY;
DRUG INDUCED DISEASE;
DRUG METABOLISM;
ENZYME ACTIVITY;
GENE DELETION;
GENE FREQUENCY;
GENETIC RISK;
GENETIC SUSCEPTIBILITY;
GENETIC VARIABILITY;
GENOTYPE;
HUMAN;
LETTER;
LIVER INJURY;
LIVER TOXICITY;
NULL ALLELE;
OXIDATIVE STRESS;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN FUNCTION;
SINGLE NUCLEOTIDE POLYMORPHISM;
|
EID: 68949091933
PISSN: 02709139
EISSN: None
Source Type: Journal
DOI: 10.1002/hep.22922 Document Type: Letter |
Times cited : (1)
|
References (5)
|